Molbio Diagnostics has partnered with Bangalore-based Niramai Health Analytix to promote and distribute the Thermalytix platform, an AI-based, non-invasive breast cancer screening solution. This collaboration aims to accelerate access to early breast cancer detection, particularly in low-resource settings globally. Thermalytix enables privacy-friendly, radiation-free, painless screening, suitable even for younger women with dense breast tissue. By adding breast cancer screening to its portfolio alongside Truenat’s cervical cancer (HPV-HR) tests, Molbio strengthens its commitment to providing universal access to critical healthcare diagnostics.
